The filing is a routine 10b5-1 plan sale by an officer; the small size and prior pattern suggest no material insider sentiment shift. Monitor the company's next earnings report for any fundamental changes.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $7.86entry
- T+1 · 6d ago −5.03%α −6.34% · $7.47
- T+5 · due 9h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Daan Van Well, an officer of SOPHiA GENETICS, filed a Form 144 notice of intent to sell 1,411 shares of common stock, with an approximate market value of $10,075 based on the filing date price. The shares were acquired via restricted stock units vested on April 28, 2022, and the sale is planned for November 9, 2026. This is a small, routine sale relative to the company's $570M market cap and the insider's prior trading activity, and it is being conducted under a 10b5-1 plan.
Key Facts
- Insider Daan Van Well (Officer) filed Form 144 to sell 1,411 shares of common stock.
- Estimated sale value: $10,074.54 based on filing date price.
- Shares acquired from restricted stock units vested on April 28, 2022.
- Sale is planned for November 9, 2026, under a 10b5-1 trading plan.
- Prior 10b5-1 sales: 6,168 shares on October 5, 2026 ($50,100) and 6,168 shares on September 11, 2026 ($47,089).
- Market cap: $570M; the proposed sale represents ~0.0018% of market cap.
Financial Impact
Proposed sale of 1,411 shares valued at approximately $10,075, a negligible fraction of the company's $570M market cap.
Risk Factors
- Insider sales under a 10b5-1 plan are pre-scheduled and do not reflect current sentiment.
- No additional context on company performance or guidance was provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010856 |
| Document: 0001950047-26-010856-index.html | 0001950047-26-010856 |
| Document: 0001950047-26-010856.txt | 0001950047-26-010856 |
Track record
47 reports on SOPH
5 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +64.11% at T+60 after the Jun 4, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry $7.45 Now $7.45 −0.00% settles Nov 25
- Nov 16, 2026today 144 Neutral 2/10 Entry $7.44 Now $7.45 +0.13% settles Nov 24
- Nov 12, 20265d ago Insider Cluster Mixed 4/10 Entry $8.21 Now $7.45 −9.26% settles Nov 20
- Nov 12, 20265d ago SC 13D/A Neutral 3/10 Entry $7.86 Now $7.45 −5.22% settles Nov 19
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $7.86 Now $7.45 −5.22% due Nov 17
- Nov 9, 20268d ago Insider Cluster Bullish 4/10 Entry $7.86 Now $7.45 −5.22% due Nov 17
- Nov 3, 202614d ago 6-K Neutral 5/10 No price data
- Nov 3, 202614d ago Press Release Neutral 5/10 Entry $6.91 to $7.86 Now $7.45 +7.81% ▲ +13.75% +14.34% vs SPY
- Oct 14, 20264w ago Insider Cluster Neutral 2/10 Entry $7.29 to $7.05 Now $7.45 +2.19% ▼ −3.29% −2.28% vs SPY
- Oct 5, 20266w ago 144 Neutral 2/10 Entry $7.38 to $7.09 Now $7.45 +0.95% ▼ −3.93% −3.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers